| ldentification of the von Hippel-Lindau disease tumor suppressor gene F Latif, K Tory, J Gnarra, M Yao, FM Duh, ML Orcutt, T Stackhouse, ... Science 260 (5112), 1317-1320, 1993 | 3606 | 1993 |
| Familial gastric cancer: overview and guidelines for management* C Caldas, F Carneiro, HT Lynch, J Yokota, GL Wiesner, SM Powell, ... Journal of Medical Genetics 36 (12), 873-880, 1999 | 811 | 1999 |
| Combenefit: an interactive platform for the analysis and visualization of drug combinations GY Di Veroli, C Fornari, D Wang, S Mollard, JL Bramhall, FM Richards, ... Bioinformatics 32 (18), 2866-2868, 2016 | 678 | 2016 |
| Germline mutations in the Von Hippel‐Lindau disease (VHL) gene in families from North America, Europe, and Japan B Zbar, T Kishida, F Chen, L Schmidt, ER Maher, FM Richards, ... Human mutation 8 (4), 348-357, 1996 | 630 | 1996 |
| Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer FM Richards, SA McKee, MH Rajpar, TRP Cole, DGR Evans, ... Human molecular genetics 8 (4), 607-610, 1999 | 440 | 1999 |
| Identification of intragenic mutations in the Von Hippel—Lindau disease tumour suppressor gene andcorrelation with disease phenotype PA Crossey, FM Richards, K Foster, A Prowse, F Latlf, MI Lerman, B Zbar, ... Human molecular genetics 3 (8), 1303-1308, 1994 | 438 | 1994 |
| Somatic mutations of the von Hippel—Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma K Foster, A Prowse, A van den Berg, S Fleming, MMF Hulsbeek, ... Human molecular genetics 3 (12), 2169-2173, 1994 | 431 | 1994 |
| Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. AH Prowse, AR Webster, FM Richards, S Richard, S Olschwang, ... American journal of human genetics 60 (4), 765, 1997 | 291 | 1997 |
| Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. ER Maher, AR Webster, FM Richards, JS Green, PA Crossey, SJ Payne, ... Journal of medical genetics 33 (4), 328-332, 1996 | 285 | 1996 |
| Epigenetic inactivation of the RASSF1A 3p21. 3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma C Morrissey, A Martinez, M Zatyka, A Agathanggelou, S Honorio, D Astuti, ... Cancer research 61 (19), 7277-7281, 2001 | 273 | 2001 |
| Zebrafish based assays for the assessment of cardiac, visual and gut function—potential safety screens for early drug discovery S Berghmans, P Butler, P Goldsmith, G Waldron, I Gardner, Z Golder, ... Journal of pharmacological and toxicological methods 58 (1), 59-68, 2008 | 219 | 2008 |
| Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer E Hessmann, MS Patzak, L Klein, N Chen, V Kari, I Ramu, TE Bapiro, ... Gut 67 (3), 497-507, 2018 | 212 | 2018 |
| Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands G Suriano, C Oliveira, P Ferreira, JC Machado, MC Bordin, O De Wever, ... Human molecular genetics 12 (5), 575-582, 2003 | 209 | 2003 |
| An automated fitting procedure and software for dose-response curves with multiphasic features. GY Veroli, C Fornari, I Goldlust, G Mills, SB Koh, JL Bramhall, ... Scientific reports 5, 14701-14701, 2014 | 208 | 2014 |
| CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response D Biasci, M Smoragiewicz, CM Connell, Z Wang, Y Gao, ... Proceedings of the National Academy of Sciences 117 (46), 28960-28970, 2020 | 196 | 2020 |
| Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a … M Zatyka, NF da Silva, SC Clifford, MR Morris, MS Wiesener, KU Eckardt, ... Cancer research 62 (13), 3803-3811, 2002 | 189 | 2002 |
| Design, Synthesis, and Biological Evaluation of an Allosteric Inhibitor of HSET that Targets Cancer Cells with Supernumerary Centrosomes CA Watts, FM Richards, A Bender, PJ Bond, O Korb, O Kern, M Riddick, ... Chemistry & biology 20 (11), 1399-1410, 2013 | 184 | 2013 |
| Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours PA Crossey, K Foster, FM Richards, ME Phipps, F Latif, K Tory, MH Jones, ... Human genetics 93 (1), 53-58, 1994 | 182 | 1994 |
| SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice A Neesse, KK Frese, DS Chan, TE Bapiro, WJ Howat, FM Richards, ... Gut 63 (6), 974-983, 2014 | 169 | 2014 |
| Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene FM Richards, SJ Payne, B Zbar, NA Affara, MA Ferguson-Smith, ... Human molecular genetics 4 (11), 2139-2143, 1995 | 156 | 1995 |
Mark MorrisUniversity of WolverhamptonVerified email at wlv.ac.uk
